BIO

Pfizer Says It’s Leaving BIO, In Major Blow To Pharmaceutical Trade Group
Pfizer Says It’s Leaving BIO, In Major Blow To Pharmaceutical Trade Group
KFF Health News
Pfizer
BIO
Flag link:
BIO welcomes John Crowley as new CEO
BIO welcomes John Crowley as new CEO
Medriva
BIO
John Crowley
Amicus Therapeutics
Flag link:
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
'By hook or by crook': BIO CEO urges biotechs to be flexible on funding to survive tough times
Fierce Biotech
BIO
biotech
funding
Inflation Reduction Act
Flag link:
Tasked with steadying BIO, Rachel King faces biotech’s many challenges
Tasked with steadying BIO, Rachel King faces biotech’s many challenges
BioPharma Dive
BIO
Rachel King
Boston
BIO 2023
Flag link:
AbbVie leaves PhRMA, BIO: reports
AbbVie leaves PhRMA, BIO: reports
Medical Marketing and Media
AbbVie
BIO
PhRMA
lobbying
Flag link:
Biotech Sector Thrives, Generating Nearly $3 Trillion Economic Impact - New Report Shows
Biotech Sector Thrives, Generating Nearly $3 Trillion Economic Impact - New Report Shows
BioSpace
BIO
biotech
jobs
Flag link:
CEO Shakeups at BIO, Passage Bio and Palisade Bio
CEO Shakeups at BIO, Passage Bio and Palisade Bio
BioSpace
BIO
Passage Bio
Palisade Bio
Maze Therapeutics
Cerecin
Pharma CEOs
Flag link:
After tough period for lobby, BIO chief Michelle McMurry-Heath goes on leave
After tough period for lobby, BIO chief Michelle McMurry-Heath goes on leave
Stat
BIO
Michelle McMurry-Heath
Flag link:
Small and Medium Biotech Companies Still Growing in Uncertain Times
Small and Medium Biotech Companies Still Growing in Uncertain Times
BioSpace
BIO
hirings
biotech
Flag link:
BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines
BIO chair slams Trump’s HHS, calls to stop Russian disinformation campaign on vaccines
Endpoints
BIO
Jeremy Levin
Russia
HHS
Donald Trump
COVID-19
vaccines
Flag link:
BIO Shakes Things Up to Align Leadership with New Vision
BIO Shakes Things Up to Align Leadership with New Vision
BioSpace
BIO
restructuring
Flag link:
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation
Xconomy
drug pricing
innovation
Donald Trump
executive order
BIO
Flag link:
Trump's meeting with pharma execs canceled after drug lobbies refuse to show up
Trump's meeting with pharma execs canceled after drug lobbies refuse to show up
Beckers Hospital Review
Donald Trump
lobbyists
BIO
drug pricing
executive orders
Flag link:
Biotechnology trade group taps former Biogen CEO as its coronavirus czar
Biotechnology trade group taps former Biogen CEO as its coronavirus czar
Reuters
BIO
George Scangos
Biogen
coronavirus
COVID-19
Flag link:
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO
Xconomy
biotech
venture capital
BIO
Flag link:
Greenwood: In Pharma Value Chain, PBMs Manage to Benefit
Greenwood: In Pharma Value Chain, PBMs Manage to Benefit
BIOTechNow
BIO
PBMs
drug pricing
Flag link:
BIO tells SEC: do away with quarterly reports for small biotechs
BIO tells SEC: do away with quarterly reports for small biotechs
Endpoints
BIO
SEC
biotechs
quarterly reports
Flag link:
BIO Calls for Innovation in Addressing the Opioid Crisis
BIO Calls for Innovation in Addressing the Opioid Crisis
BioSpace
BIO
innovation
opioids
opioid crisis
Flag link:
BIO chair: More drugmakers should pledge to not hike prices
BIO chair: More drugmakers should pledge to not hike prices
BioPharma Dive
BIO
drug pricing
Flag link:
Adaptive Trial Designs: BIO, Janssen, ACRO Call for Tweaks to FDA Draft Guidance
Adaptive Trial Designs: BIO, Janssen, ACRO Call for Tweaks to FDA Draft Guidance
RAPS.org
clinial trials
adaptive trial design
FDA
BIO
ACRO
Janssen
Flag link:

Pages